Treatment for Non-Hospitalized Patients with COVID-19
b'Credits: 0.25 AMA PRA Category 1 Credit\\u2122\\xa0\\xa0CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/Podcast/treatment-non-hospitilized-patients-covid-19\\xa0\\nOverview: Join expert faculty as they discuss risk stratification for non-hospitalized patients with mild or moderate COVID-19 to determine who would benefit most from antiviral therapy aimed at reducing the risk of progression to severe disease. Explore national guideline recommendations on COVID-19 treatment in non-hospitalized patients, including factors to consider when selecting therapy for individual patients.'